RxDoctor Payments Data

Nicola Lowrey

Medical · Orange, CANPI 1760419428

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $474,450 of the $654,576 with a category attached, or 72.5%. AbbVie accounts for 99.8% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2021 at $211,218 and has fallen 61.9% since, to $80,491 in 2025. Among medical clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$654,576in general payments, 2019–2025

Across 1,159 payments — averaging $564.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$654K
  • Merz North America, Inc.$645
  • Galderma Laboratories, L.p.$370

What the payments were for

  • Consulting fees$87,53413%
  • Speaking & faculty fees$474,45072%
  • Travel & lodging$71,45911%
  • Food & beverage$21,0083%
  • Education$1250%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)1,144$653,561
Merz North America, Inc.6$645
Galderma Laboratories, L.p.9$370

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$654,576 in reported general payments places this provider in the 95th percentile of 2,087 medical providers in California.

See all medical providers in California →

Other medical in Orange

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →